Psoriasis Treatment Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 the global Psoriasis Treatment market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.
Browse Full Report Visit – http://www.acutemarketreports.com/report/psoriasis-treatment-market
Psoriasis is a chronic, inflammatory, painful skin disease for which there is no cure with great negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation and to stop the skin cells from growing quickly. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence in some countries, significant unmet needs, promising pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of study, global psoriasis treatment market is segmented on the basis of drug class such as TNF Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its long-term safety with lower risk of infection and malignancy. Psoriasis treatment market is categorized on the basis of route of administration such as topical, oral and parenteral therapeutic drugs. Currently, topical therapeutic drugs hold largest market share due to its safety, more effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would show significant growth during forecast period because newly approved biologics are generally preferred in moderate to severe psoriasis. Psoriasis treatment market is currently dominated by North America, factors such as higher cost of therapy, higher number of psoriasis patient, government reimbursement policies fueling the growth of psoriasis treatment market in North America.
Market Competition Assessment:
The psoriasis treatment market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as AbbVie Inc., Amgen Inc., AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Stiefel Laboratories Inc. (GlaxoSmithKline plc.), Sun Pharmaceutical Industries and other.
Browse All Reports of This Category – http://www.acutemarketreports.com/category/pharmaceutical-market
Key Market Movements:
• Factors such as higher prevalence psoriasis disease, increasing treatment awareness, higher treatment compliance and favorable reimbursement policies in some countries are driving the market growth of psoriasis treatment worldwide.
• Due to the high unmet needs, vendors in the market are focusing in development of ideal treatment, promising pipeline molecule, rising access for the treatment medication in some developing countries, increase in incidence of psoriasis and skin disorders would fuel the growth of psoriasis treatment market during forecast period.
• However, patent expiry of blockbuster drugs leads to generic erosion and adverse effects associated with the use of medication which would negatively impact the growth of psoriasis treatment market.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Psoriasis Treatment Market Snapshot
2.2 Global Psoriasis Treatment Market, by Drug Class, 2016 (US$ Bn)
2.3 Global Psoriasis Treatment Market, by Route of Administration, 2016 (US$ Bn)
2.4 Global Psoriasis Treatment Market Share, by Geography, 2016 (Value %)
Chapter 3 Psoriasis Treatment Market Analysis
3.1 Global Psoriasis Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
188.8.131.52 Higher prevalence of Psoriasis
184.108.40.206 Promising pipeline molecules
220.127.116.11 Higher unmet needs
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Psoriasis Treatment Market
Chapter 4 Global Psoriasis Treatment Market, by Drug Class
4.2 TNF Inhibitors
4.3 Vitamin D Analogues
4.4 Interleukin Blockers
4.5 Topical Corticosteroids
Chapter 5 Global Psoriasis Treatment Market, by Route of Administration
5.2 Topical Therapeutic Drugs
5.3 Oral Therapeutic Drugs
5.4 Parenteral Therapeutic Drugs
Chapter 6 Global Psoriasis Treatment Market, By Geography
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan and Rest of APAC)
6.5 Latin America
6.6 Middle East and Africa
To Get Complete Report @ http://www.acutemarketreports.com/report/psoriasis-treatment-market
Chapter 7 Company Profiles
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.5 Boehringer Ingelheim
7.7 Eli Lilly and Company
7.8 Johnson & Johnson
7.9 LEO Pharma A/S
7.10 Merck & Co., Inc.
7.11 Novartis AG
7.12 Pfizer, Inc.
7.13 Stiefel Laboratories Inc. (GlaxoSmithKline plc)
7.14 Sun Pharmaceutical Industries
Latest Reports :
About – Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : firstname.lastname@example.org
Website : http://www.acutemarketreports.com
Our Blog :- http://www.pdfdevices.com/